Back to Search
JANET MCGILL, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1811915325IndividualAccepts Medicare
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
R9E30(MO)
Education
MICHIGAN STATE UNIVERSITY COLLEGE OF HUMAN MEDICINE
Class of 1979
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Breath Acetone Correlates With Capillary β-hydroxybutyrate in Type 1 Diabetes.
PMID 40260699·J Diabetes Sci Technol·2025
8-other
Breath Acetone Correlates with Capillary β-hydroxybutyrate in Type 1 Diabetes.
PMID 39974120·medRxiv·2025
8-other
The correlation between breath acetone and blood betahydroxybutyrate in individuals with type 1 diabetes.
PMID 33027776·J Breath Res·2020
8-other
Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes.
PMID 32641376·Diabetes Care·2020
2-rct
Characterization of a high-resolution breath acetone meter for ketosis monitoring.
PMID 33024634·PeerJ·2020
8-other
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial.
PMID 30026335·Diabetes Care·2018
3-trial
Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol.
PMID 30129772·Diabetes Technol Ther·2018
8-other
Altered Patterns of Early Metabolic Decompensation in Type 1 Diabetes During Treatment with a SGLT2 Inhibitor: An Insulin Pump Suspension Study.
PMID 29068709·Diabetes Technol Ther·2017
8-other
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
PMID 28919061·Lancet Diabetes Endocrinol·2017
3-trial
A Negative Correlation Between Blood Glucose and Acetone Measured in Healthy and Type 1 Diabetes Mellitus Patient Breath.
PMID 25691653·J Diabetes Sci Technol·2015
4-observational
Breath acetone concentration; biological variability and the influence of diet.
PMID 21725144·Physiol Meas·2011
8-other
Impact of incretin therapy on islet dysfunction: an underlying defect in the pathophysiology of type 2 diabetes.
PMID 19179813·Postgrad Med·2009
8-other
Improving microvascular outcomes in patients with diabetes through management of hypertension.
PMID 19332966·Postgrad Med·2009
6-review
Progress and controversies: treating obesity and insulin resistance in the context of hypertension.
PMID 19125857·J Clin Hypertens (Greenwich)·2009
6-review
Insights from the Liraglutide Clinical Development Program--the Liraglutide Effect and Action in Diabetes (LEAD) studies.
PMID 19491536·Postgrad Med·2009
6-review
beta-blocker use and diabetes symptom score: results from the GEMINI study.
PMID 17391169·Diabetes Obes Metab·2007
4-observational
Clinical safety of the selective PKC-beta inhibitor, ruboxistaurin.
PMID 17044810·Expert Opin Drug Saf·2006
6-review
A review of the use of olopatadine in allergic conjunctivitis.
PMID 15847317·Int Ophthalmol·2004
6-review
Innate immune control and regulation of influenza virus infections.
PMID 19643736·J Leukoc Biol·2009
6-review
Expanded newborn screening: outcome in screened and unscreened patients at age 6 years.
PMID 19620191·Pediatrics·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4921 PARKVIEW PL, DIV IM ENDOCRINOLOGY, STE 5C
SAINT LOUIS, MO 63110 - Phone
- (314) 362-3500
Quick Facts
- NPI
- 1811915325
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 47
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile